PMC9791213_01
(A, B) Contrast-enhanced CT scan showed multiple low-density tumors of various sizes in the pelvis and liver, and the largest liver metastatic tumor was 4.6cmx3.9cm. (C, D) A contrast-enhanced CT scan after three courses of treatment showed that the tumors in the pelvis and liver had shrunk significantly. (E, F) After ten cycles of treatment, CR was observed. (G, H). The patient had been disease free for 41 months. Figures G and F are the most recent follow-up results.
fonc-12-1020793-g001.jpg
PMC9791213_01_fonc-12-1020793-g001.jpg
f1
In January 2019, the abdomen enhanced CT showed multiple metastases in liver and pelvic cavity ( Figures 1A, B ). On March 1, 2019, after the patient had finished 3 cycles of combined therapy, the whole abdomen enhanced CT showed that liver and pelvic metastases were reduced significantly ( Figures 1C, D ). On August 10, 2019, after 9 cycles, the patient achieved CR ( Figures 1E, F ). The disease has been kept CR for more than 41 months and is still being followed up without recurrence and adverse events ( Figures 1G, H ).